Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN & C3G
  - Search for:
- Neurology
  - BACK
  - Neurology
  - Alzheimer's Disease
  - Epilepsy
  - Insomnia
  - Migraine
  - Multiple Sclerosis
  - Tuberous Sclerosis Complex
  - Search for:
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Conference Calendar
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Ophthalmology

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Treatment Challenges in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

expert roundtables
By Peter Campochiaro, MD; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Exploring the Potential for a Lower Treatment Burden in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

expert roundtables
By Peter Campochiaro, MD; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Predicting Outcomes With Anti-VEGF Treatment in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

expert roundtables
By Peter Campochiaro, MD; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Retinal Imaging in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Advancements in Screening and Monitoring

expert roundtables
By Peter Campochiaro, MD; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Browse Perspectives by Categories in Ophthalmology

Advertisment

Ophthalmology Conference Reporter

Novel Disease Biomarkers and Artificial Intelligence in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Optical Coherence Tomography and Multimodal Diagnostics in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Geographic Atrophy in Age-Related Macular Degeneration: Novel Strategies Targeting the Complement System

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

The Natural History of Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

Latest in Ophthalmology

Frontiers and Innovation in the Approach to Diabetic Macular Edema

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Frontiers and Innovation in the Approach to Diabetic Macular Edema

patient care perspectives
By Peter Campochiaro, MD

Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy

patient care perspectives
By SriniVas R. Sadda, MD, FARVO

Treat-and-Extend Intravitreal Dosing Regimens for Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Treat-and-Extend Intravitreal Dosing Regimens for Neovascular Age-Related Macular Degeneration

patient care perspectives
By Peter K. Kaiser, MD

The Emerging Role of Artificial Intelligence in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

The Emerging Role of Artificial Intelligence in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

clinical topic updates
By SriniVas R. Sadda, MD, FARVO

Updates in Clinical Imaging of the Retina: Correlating Images and Disease

Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Updates in Clinical Imaging of the Retina: Correlating Images and Disease

clinical topic updates
By SriniVas R. Sadda, MD, FARVO

Load More

Advertisment

2024 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

By submitting a new user registration you’re agreeing to the Privacy Policy and Terms of Service for Expert Perspectives in Medicine and its subsidiaries.